VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mkilloran who wrote (18381)	1/29/1999 8:58:00 PM
From: DaiS	Read Replies (1) of 23519

>>The delay IMO is waiting for the 6 week study period in the UK that the NHS has started.>> MK, There has to be some explanation for delay in EU but I am not convinced by this explanation. The health systems vary widely in different EU countries. Viagra is approved why not muse? If UK decides to approve ED treatments on NHS ad libitum...or UK decides to be highly restrictive what difference does this make to muse approval in other EU countries? Of course if NHS is restrictive, French might tell us to %$£$ off and do the opposite. On another point, all the communications that I have had from Astra suggest that is is the responsibility of Astra to seek approval not Vivus. Why should Astra hurry too much? OK they might upset Vivus a bit, otherwise they should choose best time for launches, evidently no hurry at the moment. DaiS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next